Toxoplasma gondii, the Immune system, and suicidal behavior

The Neurobiological Basis of Suicide

Volumn , Issue , 2012, Pages 381-405

  Okusaga, Olaoluwa ^a,b   Postolache, Teodor T ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Baltimore VA Medical Center ^*  (United States)

^c BALTIMORE VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84982167734     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b12215     Document Type: Chapter

References (102)

1. Ajioka, J.W., Soldati, D. 2007. Toxoplasma Molecular and Cellular Biology. Norfolk, U.K.: Horizon Bioscience.
2. Aliberti, J. 2005. Host persistence: Exploitation of anti-inflammatory pathways by T. gondii. Nat Rev Immunol. 5: 162-170.
3. Andersen, T.F., Madsen, M., Jorgensen, J. et al. 1999. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 46:263-268.
4. Arling, T.A., Yolken, R.H., Lapidus, M. et al. 2009. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis. 197: 905-908.
5. Berdoy, M., Webster, J.P., Macdonald, D.W. 2000. Fatal attraction in rats infected with T. gondii. Proc Biol Sci. 267: 1591-1594.
6. Berretta, N., Nistico, R., Bernadi, G. et al. 2008. Synaptic plasticity in the basal ganglia: A similar code for physiological and pathological conditions. Prog Neurobiol. 84: 343-362.
7. Bhat, R., Steinman, L. 2009. Innate and adaptive autoimmunity directed to the central nervous system. Neuron. 64: 123-132.
8. Bonilla, F.A., Oettgen, H.C. 2010. Adaptive immunity. J Allergy Clin Immunol. 125: S33-S40.
9. Buzoni-Gatel, D., Debbabi, H., Mennechet, F.J. et al. 2001. Murine ileitis after intracellular parasite infection is controlled by TGF-beta-producing intraepithelial lymphocytes. Gastroenterology. 120: 914-924.
10. Centers for disease control and prevention. 2010. Toxoplasmosis. http://www.cdc.gov/parasites/toxoplasmosis/; last reviewed November 2, 2010. Accessed February 1, 2011.
11. Chao, C.C., Hu, S., Gekker, G. et al. 1993. Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. J Immunol. 150: 3404-3410.
12. Chaplin, D. 2010. Overview of the immune response. J Allergy Clin Immunol. 125: S3-S23.
13. Commins, S.P., Borish, L., Steinke, J.W. 2010. Immunologic messenger molecules: Cytokines, interferons, and chemokines. J Allergy Clin Immunol. 125: S53-S72.
14. Courret, N., Darche, S., Sonigo, P. et al. 2006. CD11c- and CD11b-expressing mouse leuko-cytes transport single Toxoplasma gondii tachyzoites to the brain. Blood. 107: 309-316.
15. Dantzer, R. 2009. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 29: 247-264.
16. Dantzer, R., O’Connor J.C., Freund, G.G. et al. 2008. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci. 9: 46-56.
17. Dantzer, R., O’Connor, J.C., Lawson, M.A. et al. 2011. Inflammation-associated depression: From serotonin to kynurenine. Psychoneuroendocrinology. 36: 426-436.
18. Denkers, E.Y., Gazzinelli, R.T. 1998. Regulation and function of T-cell-mediated immunity during T. gondii infection. Clin Microbiol Rev. 11: 569-588.
19. Diana, J., Vincent, C., Peyron, F. et al. 2005. Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors. Clin Exp Immunol. 141: 475-484.
20. Duman, R.S. 2009. Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: Stress and depression. Dialogues Clin Neurosci. 11: 239-255.
21. Dursun, S.M., Blackburn, J.R., Kutcher, S.P. 2001. An exploratory approach to the sero-tonergic hypothesis of depression: Bridging the synaptic gap. Med Hypotheses. 56: 235-243.
22. Egan, C.E., Dalton, J.E., Andrew, E.M. et al. 2005. Requirement for the Vgamma1+ subset of peripheral gamma delta T cells in the control of the systemic growth of Toxoplasma gondii and infection-induced pathology. J Immunol. 175: 8191-8199.
23. First, M.B. 2003. Standardized evaluation in clinical practice. In Review of Psychiatry, J.M. Oldham, M.B. Riba, eds., p. 167. Washington, DC: American Psychiatric Publishing.
24. Fischer, H.G., Bonifas, U., Reichmann, G. 2000. Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J Immunol. 164: 4826-4834.
25. Fischer, H.G., Nitzgen, B., Reichmann, G. et al. 1997. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Eur J Immunol. 27: 1539-1548.
26. Flegr, J. 2007. Effects of T. gondii on human behavior. Schizophr Bull. 33: 757-760.
27. Flegr, J., Havlicek, J., Kodym, P. et al. 2002. Increased risk of traffic accidents in subjects with latent toxoplasmosis: A retrospective case-control study. BMC Infect Dis. 2: 11.
28. Gaskell, E.A., Smith, J.E., Pinney, J.W. 2009. A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One. 4: e4801.
29. Gazzinelli, R.T., Eltoum, I., Wynn, T.A. et al. 1993a. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expres-sion of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol. 151: 3672-3681.
30. Gazzinelli, R.T., Hieny, S., Wynn, T.A. et al. 1993b. Interleukin 12 is required for the T lymphocyte-independent induction of interferon gamma by an intracellular par-asite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U. S. A. 90: 6115-6119.
31. Gazzinelli, R.T., Wysocka, M., Hieny, S. et al. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol. 157: 798-805.
32. Gilliet, M., Cao, W., Liu, Y.J. 2008. Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 8: 594-606.
33. Harris, E.C., Barraclough, B. 1997. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 170: 205-228.
34. Hawton, K., van Heering, K. 2009. Suicide. Lancet. 373: 1372-1381.
35. Hay, J., Aitken, P.P., Hair, D.M. et al. 1984. The effect of congenital T. gondii infection on mouse activity and relative preference for exposed areas over a series of trials. Ann Trop Med Parasitol. 78: 611-618.
36. Hunter, C.A., Abrams, J.S., Beaman, M.H. et al. 1993. Cytokine mRNA in the central ner-vous system of SCID mice infected with Toxoplasma gondii: Importance of T-cell-independent regulation of resistance to T. gondii. Infect Immun. 61: 4038-4044.
37. Hunter, C.A., Remington, J.S. 1994. Immunopathogenesis of toxoplasmic encephalitis. J Infect Dis. 170: 1057-1067.
38. Israelski, D.M., Remington, J.S. 1993. Toxoplasmosis in patients with cancer. Clin Infect Dis. 17(Suppl 2): S423-S435.
39. Israelski, D.M., Chmiel, J.S., Poggensee, L. et al. 1993. Prevalence of toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. J Acquir Immune Defic Syndr. 6: 414-418.
40. Janelidze, S., Mattei, D., Westrin, Å. et al. 2010. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun. 25: 335-339.
41. Joiner, T.E. Jr, Van Orden, K.A., Witte, T.K. 2009. Main predictions of the interpersonal-psy-chological theory of suicidal behavior: Empirical tests in two samples of young adults. J Abnorm Psychol. 118: 634-646.
42. Juel, K., Helweg-Larsen, K. 1999. The Danish registers of causes of death. Dan Med Bull. 46: 354-357.
43. Kovacsics, C.E., Gottesman, I.I., Gould, T.D. 2009. Lithium’s antisuicidal efficacy: Elucidation of neurobiological targets using endophenotype strategies. Annu Rev Pharmacol Toxicol. 49: 175-198.
44. Lamberton, P.H., Donnelly, C.A., Webster, J.P. 2008. Specificity of the T. gondii altered behavior to definitive versus non-definitive host predation risk. Parasitology. 135: 1143-1150.
45. Lebech, M., Petersen, E. 1995. Detection by enzyme immunosorbent assay of Toxoplasma gondii IgG antibodies in dried blood spots on PKU-filter paper from newborns. Scand J Infect Dis. 27: 259-263.
46. Lester, D. 2010. Brain parasites and suicide. Psychol Rep. 107: 424.
47. Leweke, F.M., Gerth, C.W., Koethe, D. et al. 2004. Antibodies to infectious agents in individu-als with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci. 254: 4-8.
48. Liesenfeld, O., Kosek, J., Remington, J.S. et al. 1996. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med. 184: 597-607.
49. Lindqvist, D. 2010. Refining Suicidal Behavior: Rating Scales and Biomarkers. Lund, Sweden: University Press.
50. Lindqvist, D., Janelidze, S., Hagell, P. et al. 2009. Interleukin-6 is elevated in the cerebro-spinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry. 66: 287-292.
51. Ling, V.J., Lester, D., Mortensen, P.B. et al. 2011. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis. 199:440-444.
52. Loftis, J.M., Huckans, M., Morasco, B.J. 2010. Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies. Neurobiol Dis. 37: 519-533.
53. Luangsay, S., Kasper, L.H., Rachinel, N. et al. 2003. CCR5 mediates specific migration of Toxoplasma gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells. Gastroenterology. 125: 491-500.
54. Mann, J.J. 2003. Neurobiology of suicidal behavior. Nat Rev Neurosci. 4: 819-828.
55. Mann, J.J., Arango, V.A., Avenevoli, S. et al. 2009. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry. 65: 556-563.
56. McAllister, K.A., van de Water, J. 2009. Breaking boundaries in neural-immune interactions. Neuron. 64: 9-12.
57. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat Rev Immunol. 1: 135-145.
58. Mehta, P.H., Beer, J. 2010. Neural mechanisms of the testosterone-aggression relation: The role of orbitofrontal cortex. J Cogn Neurosci. 22: 2357-2368.
59. Miller, C.M., Boulter, N.R., Ikin, R.J. et al. 2009. The immunobiology of the innate response to T. gondii. Int J Parasitol. 39: 23-39.
60. Montoya, J.G., Liesenfeld, O. 2004. Toxoplasmosis. Lancet. 363: 1965-1976.
61. Mordue, D.G., Monroy, F., La Regina, M. et al. 2001. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol. 167: 4574-4584.
62. Müller, N., Myint, A.-M, Schwarz, M.J. 2009. The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders-Relation to drug treatment. Dialogues Clin Neurosci. 11: 319-332.
63. Munk-Jorgensen, P., Mortensen, P.B. 1997. The Danish Psychiatric Central Register. Dan Med Bull. 44: 82-84.
64. Nassberger, L., Traskman-Bendz, L. 1993. Increased soluble interleukin-2 receptor concentra-tions in suicide attempters. Acta Psychiatr Scand. 88: 48-52.
65. Nickdel, M.B., Lyons, R.E., Roberts, F., Brombacher, F., Hunter, C.A., Alexander, J., Roberts, C.W. 2004. Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unre-lated to parasite burden. Parasite Immunol. 26: 75-82.
66. Niebuhr, D.W., Millikan, A.M., Cowan, D.N. et al. 2008. Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry. 165: 99-106.
67. Okusaga, O., Langenberg, P., Sleemi, A. et al. 2011. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res. 133: 150-155.
68. Oquendo, M.A., Halberstam, B., Mann, J.J. 2003. Risk factors for suicidal behavior: The utility and limitations of research instruments. In Standardized Evaluation in Clinical Practice, M.B. First, ed., pp. 103-130. Arlington, VA: American Psychiatric Publishing.
69. Osborn, D., Levy, G., Nazareth, I., King, M. 2008. Suicide and severe mental illnesses. Cohort study within the UK general practice research database. Schizophr Res. 99: 134-138.
70. Paraskevas, F. 2004. T Lymphocytes and natural killer cells. In Wintrobe’s Clinical Hematology, J.P. Greer, J. Foerster, J.N. Lukens, G.M. Rodgers, F. Paraskevas, B. Glader, eds., p. 491. Philadelphia, PA: Lippincott Williams & Wilkins.
71. Pedersen, C.B., Gotzsche, H., Moller, J.O. et al. 2006. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 53: 441-449.
72. Pedersen, M.G, Mortensen, P.B., Nørgaard-Pedersen, B. et al. 2012. Toxoplasma gondii infec-tion and deliberate self-harm in mothers (submitted).
73. Pepper, M., Hunter, C.A. 2007. Innate recognition and the regulation of protective immunity to Toxoplasma gondii. In Toxoplasma: Molecular and Cellular Biology, J.W. Ajioka, D. Soldati, eds. Norfolk, U.K.: Horizon Bioscience.
74. Postolache, T.T., Mortensen, P.B., Tonelli, L.H. et al. 2010. Seasonal spring peaks of suicide in victims with and without prior history of hospitalization for mood disorders. J Affect Disord. 121: 88-93.
75. Postolache, T.T., Stiller, J.W., Herrell, R. et al. 2005. Tree pollen peaks are associated with increased nonviolent suicide in women. Mol Psychiatry. 10: 232-235.
76. Qin, P., Mortensen, P.B., Waltoft, B.L. et al. 2011. Allergy is associated with suicide com-pletion with a possible mediating role of mood disorder-A population-based study. Allergy. 66: 658-664.
77. Qin, P., Waltoft, B.L., Mortensen, P.B. et al. 2012. Incidents of suicide death are associated with pollen counts in the environment-A study based on Danish longitudinal data (under review).
78. Raison, C.L., Capuron, L., Miller, A.H. 2006. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol. 27: 24-31.
79. Raison, C.L., Dantzer, R., Kelley, K.W. et al. 2010. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: Relationship to CNS immune responses and depression. Mol Psychiatry. 15: 393-403.
80. Raposo, G., Tenza, D., Mecheri, S. et al. 1997. Accumulation of major histocompatibility com-plex class II molecules in mast cell secretory granules and their release upon degranula-tion. Mol Biol Cell. 8: 2631-2645.
81. Schroeder, H.W., Cavacini, L. 2010. Structure and function of immunoglobulins. J Allergy Clin Immunol. 125: S41-S52.
82. Schwarcz, R., Pellicciari, R. 2002. Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther. 303: 1-10.
83. Smiley, S.T., Lanthier, P.A., Couper, K.N., Szaba, F.M., Boyson, J.E., Chen, W., Johnson, L.L. 2005. Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice. J Immunol. 174: 7904-7911.
84. Speer, C.A., Dubey, J.P. 2005. Ultrastructural differentiation of Toxoplasma gondii schizonts (types B to E) and gamonts in the intestines of cats fed bradyzoites. Int J Parasitol. 35: 193-206.
85. Steiner, J., Bielau, H., Brisch, R. et al. 2008. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res. 42: 151-157.
86. Stone, K.D., Prussin, C., Metcalfe, D.D. 2010. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 125: S73-S80.
87. Sublette, M.E., Galfalvy, H.C., Fuchs, D., Lapidus, M., Grunebaum, M.F., Oquendo, M.A., Mann, J.J., Postolache, T.T. 2011. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun. 25:1272-1278.
88. Tansey, M.G. 2010. Inflammation in neuropsychiatric disease (Editorial). Neurobiol Dis. 37: 491-492.
89. Tonelli, L.H., Hoshino, A., Katz, M. et al. 2008a. Acute stress promotes aggressive-like behavior in rats made allergic to tree pollen. Int J Child Health Hum Dev. 1: 305-312.
90. Tonelli, L.H., Katz, M., Kovacsics, C.E. et al. 2009. Allergic rhinitis induces anxiety-like behavior and altered social interaction in rodents. Brain Behav Immun. 23: 784-793.
91. Tonelli, L.H., Stiller, J., Rujescu, D. et al. 2008b. Elevated cytokine expression in the orbito-frontal cortex of victims of suicide. Acta Psychiatr Scand. 117: 198-206.
92. Torrey, E.F., Bartko, J.J., Lun, Z.R. et al. 2007. Antibodies to T. gondii in patients with schizo-phrenia: A meta-analysis. Schizophr Bull. 33: 729-736.
93. Träskman, L., Åsberg, M., Bertilsson, L. et al. 1981. Monoamine metabolites in CSF and sui-cidal behavior. Arch Gen Psychiatry. 38: 631-634.
94. Turvey, S.E., Broide, D.H. 2010. Innate immunity. J Allergy. 25: S24-S32.
95. Vyas, A., Kim, S.K., Giacomini, N. et al. 2007. Behavioral changes induced by T. gondii infec-tion of rodents are highly specific to aversion of cat odors. Proc Natl Acad Sci U. S. A. 104: 6442-6447.
96. Wasserman, E.E., Nelson, K., Rose, N.R. et al. 2009. Infection and thyroid autoimmunity: A seroepidemiologic study of TPOaAb. Autoimmunity. 42(5): 439-446.
97. Webster, J.P. 2007. The effect of T. gondii on animal behavior: Playing cat and mouse. Schizophr Bull. 33:752-756.
98. Wilson, M., McAuley, J.B. 1999. Toxoplasma. In Manual of Clinical Microbiology. P.R. Murray, E.J. Baron, M.A. Pfaller et al., eds., pp. 1374-1382. Washington, DC: ASM Press.
99. Wonodi, I., Schwarcz, R. 2010. Cortical kynurenine pathway metabolism: A novel target for cognitive enhancement in schizophrenia. Schizophr Bull. 36: 211-218.
100. World Health Organization (WHO). 1994. WHO ICD-10: Mental and Behavioural Disorders. Classification and Diagnostic Criteria. Copenhagen, Denmark: WHO.
101. Yagmur, F., Yazar, S., Temel, H.O. et al. 2010. May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int. 199: 15-17.
102. Young, J.D., McGwire, B.S. 2005. Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med. 353: 1530-1531.